THE MISSING COMPANY?

Part Three – Bermuda, Transparency and the Questions Every Patient Should Ask

Throughout this investigation we have deliberately avoided making accusations.

Instead, we have followed the evidence that is publicly available and asked a series of questions that any prospective patient could reasonably ask before committing to expensive medical treatment.

Our investigation began with something as simple as a LinkedIn profile.

It then led us into questions about corporate identity, public records, organisational structure and transparency.

One location appeared repeatedly throughout that journey.

Hamilton, Bermuda.

But what does that actually mean?

And why does it matter?

Bermuda is not the story

Let us be clear from the outset.

Being headquartered in Bermuda is not, by itself, evidence of wrongdoing.

Many reputable international businesses are incorporated there for a variety of commercial, legal and tax reasons.

There is nothing inherently improper about choosing Bermuda as a corporate base.

The purpose of this article is not to criticise that decision.

Instead, it is to explore how that choice may affect the ability of prospective patients to independently verify information about the organisation they are considering.

Transparency and public records

One of the strengths of many corporate registers is that they allow members of the public to understand the legal identity of a business.

Depending on the jurisdiction, public filings may include information such as:

• Directors

• Registered offices

• Annual accounts

• Confirmation statements

• Corporate history

• Shareholders or controlling interests

• Financial disclosures

These records help consumers, journalists, regulators and researchers understand who they are dealing with.

They provide transparency.

Why transparency matters in healthcare

Healthcare is unlike most other industries.

Patients are often making decisions while living with pain, disability or serious illness.

Many invest significant sums of money.

Some travel internationally.

Some place enormous trust in organisations they have never previously encountered.

For those reasons, transparency becomes more than good corporate practice.

It becomes part of informed consent.

Knowing who stands behind an organisation can be just as important as understanding the treatment itself.

The challenge for patients

During our investigation, we found ourselves repeatedly asking the same question:

How can an ordinary patient independently verify the organisation behind the marketing?

For many people, that journey begins online.

They may read testimonials.

Watch interviews.

Visit social media pages.

Browse professional-looking websites.

What they may not know is how to establish:

• Which legal entity is providing the service.

• Which jurisdiction governs that entity.

• Where public corporate information can be reviewed.

• Which organisation ultimately carries legal responsibility.

These questions are not unique to regenerative medicine.

They apply to any international healthcare provider.

Questions are not accusations

Throughout this series we have deliberately focused on asking questions rather than drawing conclusions.

Good investigations begin with curiosity.

They do not begin with assumptions.

The absence of readily accessible public information does not prove that something is wrong.

Equally, professional marketing alone should never replace independent verification.

The safest approach lies somewhere between those two positions.

Ask questions.

Seek evidence.

Understand who you are trusting.

What we have learned

Three themes have emerged from our investigation.

First, understanding the legal identity of an organisation is an essential part of informed decision-making.

Second, large international healthcare operations typically require extensive clinical, scientific, administrative and regulatory infrastructure.

Finally, transparency helps patients make informed choices.

When information is easy to verify, confidence tends to increase.

When it is difficult to verify, patients may quite reasonably ask for greater clarity before proceeding.

Our investigation continues

This series has not been about proving guilt or innocence.

It has been about understanding.

As investigators, we believe the most valuable service we can provide is encouraging people to ask informed questions before making important decisions about their health.

That principle applies equally to every clinic, every provider and every healthcare organisation.

Transparency benefits everyone.

Patients deserve clear information.

Responsible organisations benefit from public confidence.

And difficult questions, when asked fairly and respectfully, often lead to better answers.

Coming Next: Following the Corporate Trail

Although this concludes the first chapter of our investigation, it certainly does not conclude the story.

In the next series, we intend to follow the corporate trail and investigate Wellbeing International further.

Among the questions we hope to explore are:

• Which legal entity contracts with patients?

• Which organisation receives payment for treatment?

• Who employs the individuals involved in patient care?

• Which laboratories are used, and under what regulatory framework do they operate?

• How are patient complaints handled across different jurisdictions?

• Which insurers provide professional indemnity cover?

• What regulatory approvals apply to the therapies being promoted?

• How are international partnerships structured?

• What protections are available if treatment does not go as expected?

These are not allegations.

They are simply the next logical questions in an investigation that began with one simple objective:

To help patients make informed decisions by understanding who stands behind the treatment they are being offered from Wellbeing International Foundation Ltd.

The search for answers continues.